Marshfield Clinic encourages inventors in activities of research and innovation that foster discovery.
The goals of this process include:
- To provide better outcomes for patients
- To create faster solutions at lower cost
- To corroborate discoveries and participate in a meaningful dialogue
- To gain respect from the industry as an expert this leads to collaboration and consultation
- To provide innovative solutions to today's health care related problems
Join us each month for
The commercialization process
The commercialization process ensures that each promising technology receives the critical mass required to proceed to market as effectively and efficiently as possible.
Our goal is to have a process that is educational, engaging, and enjoyable for inventors and ultimately beneficial for patients everywhere.
Download and complete an
Invention Disclosure Form (IDF). Submit it to firstname.lastname@example.org or
Work with the Innovation Manager for your Institute to prepare your invention for presentation at the appropriate Peer Review Committee (PRC).
The invention is presented to a clinical or administrative-specific PRC to be assessed and scored for clinical/technical efficacy. Based on the aggregate score and feedback from clinical and technical experts, a recommendation will be made to evaluate the invention for commercial viability or to close the case.
Inventions believed to have clinical and technical merit are transitioned into an Incubators for consideration: Medical Devices; Therapeutics and Diagnostics; or Health Information Technology.
A business case for the invention is prepared, and the commercial viability and path forward are determined then presented to Marshfield Clinic's Technology Transfer & Commercialization Committee.
A development plan for the invention is prepared and executed.
Market is contacted to garner interest and gather relevant feedback. The commercialization strategy is refined and inventions are marketed.
Negotiations are initiated with interested corporate partners or investors.
Licenses are executed and new companies are formed. Commercialization activities are now the responsibility of the licensee and/or new company.
Licenses are closely monitored to ensure commercialization activities by the Licensee are on track and new companies are operated until appropriately staffed. New companies are governed by Marshfield Clinic's Board of Directors until goals of improving patient care are realized.
Cases may be closed at any point during the Need Assessment, Viability Assessment, Enhancement, or Negotiation stages. Cases are closed when clinical need or efficacy is not established by the Peer Review Committee, the invention is deemed not commercially viable, not protectable, or unfeasible by the Incubator, or deemed not marketable by various corporate partners or investors.
Cases may also be temporarily closed if they are not sufficiently fleshed out or ready for market entry. In these instances, inventions will be returned to the inventor for further refinement.
Benefits of patenting & inventing
- The benefits of patenting an invention through Marshfield Clinic:
- Patent costs and legal fees for accepted disclosures are covered
- Patents are a method of publication
- Experienced innovation officers guide inventors through the patenting process
- Industry contacts and experience negotiating contracts that work
- License agreements provide income to the inventors
- Inventors' departments or research areas also benefit from licensed inventions
- Patenting is a method for translating work into products that benefit society
- Patent holders can prevent abuse or misuse of their inventions and research
Marshfield Clinic shares the royalty revenue generated by a licensed technology with the technology's inventor(s) or author(s); the inventors' clinical or research departments; and Marshfield Clinic Research Institute.